Measures of the diagnostic potential of the differentiation of NSCLC patients with EGFR exon 19 deletion (EGFR19DEL) or EGFR p.L858R mutations (EGFRp.L858R) versus EGFR wild-type (EGFRWT) patients. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.